You are currently viewing a new version of our website. To view the old version click .

Experimental Urooncology—New Insights from Basic and Translational Research

This special issue belongs to the section “Medical Research“.

Special Issue Information

Dear Colleagues,

Urological cancers have increased significantly in recent years and are expected to increase by 23% until 2030. This prediction includes cancers of the kidney, ureter, bladder, urethra, penis, prostate, and testicles. Recent clinical trials show encouraging results, and the prognosis of urological tumors can often be transformed from life-threatening to chronic disease. In particular, significant progress has been made in the treatment of locally advanced and metastatic prostate and renal cell cancer. However, despite significant research efforts and new treatment options, treatment failure and the development of resistance are still the most critical challenges in everyday clinical practice. Against this background, the development of new and complementary therapeutic strategies in urooncology is mandatory.

This Special Issue aims to publish original works and reviews that highlight the potential of experimental therapeutic approaches and strategies from basic and translational research targeting urological cancers.

Dr. Holger Hans Herman Erb
Dr. Matthias Stope
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • urooncology
  • experimental therapy approaches
  • urology
  • drug targets
  • therapy resistance
  • translational urology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Life - ISSN 2075-1729